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Influenza virus infections continue to cause 
significant morbidity and mortality worldwide, 
and they place a considerable economic bur-
den on individuals, families, businesses, and 
health care providers. Seasonal flu epidemics 
cause tens of millions of respiratory illnesses 
and 250,000–500,000 deaths worldwide each 
year [World Health Organization (WHO) 
2003]. During the 20th century, flu pandem-
ics caused millions of deaths, social disruption, 
and profound economic losses. The outbreak 
of the “Spanish flu” in 1918 was the worst, 
causing an estimated 40 million deaths world-
wide, including 390,000 in Japan (Ministry of 
Health, Labour and Welfare of Japan 2005). 
Influenza pandemics occur when a new strain 
of the influenza virus is transmitted to humans 
from animals. Species thought to be impor-
tant in the emergence of new human strains 
are ducks, chickens, and pigs. Recent emer-
gences of highly pathogenic avian influenza 
virus (H5N1) and reports of flu virus resis-
tance to antiviral drugs are of great concern. 
Two groups of anti  viral drugs are used for the 
treatment of flu: the neuraminidase inhibitors 
(e.g., Tamiflu) and the M2 ion channel inhibi-
tors (e.g., amantadine). Oseltamivir phosphate 
(OP; Figure 1), marketed as Tamiflu, is rec-
ommended by the WHO for both treatment 
of influenza and prophylaxis and is considered 
an important first-line defense in the event of 
a flu pandemic. OP is a prodrug that is rap-
idly and extensively hydrolyzed in vivo to its 
active metabolite, oseltamivir carboxylate (OC; 
Figure 1), a potent and selective inhibitor of 
influenza A and B virus neuraminidase. OC 
is excreted (> 80% of oral dose) unchanged 
(Sweetman 2007).
OP is widely used in Japan. As with many 
other pharmacologically active compounds, 
sewage treatment plant (STP) effluent is 
the main source of OC in the environment 
because OC is not removed significantly in 
STPs (Fick et al. 2007). The most widespread 
subtypes of influenza A virus are transmitted 
through water  fowl, where they remain, mul-
tiply, and are excreted in large quantities in 
droppings (Olsen et al. 2006). Notably, water-
fowl stay close to STP discharge points, where 
the water temperature is higher and where 
they find adequate food, especially in win-
ter, the flu season. Therefore, widespread use 
of OP to fight seasonal influenza in humans 
could lead to the development of OC-resistant 
strains of the viruses in wild birds (Fick et al. 
2007; Singer et al. 2007). In addition, a mass 
administration of OP during a future pan-
demic could pose a risk to drinking water 
safety and ecologic health.
In the present study we developed 
a method for the detection of OC in STP 
discharge and in river water using solid-
phase extraction (SPE) followed by liquid 
chromatography–tandem mass spectrometry 
(LC-MS/MS), and investigated the occur-
rence of OC in STP effluent and receiving 
river water during the 2008–2009 flu season 
in Kyoto City, Japan.
Materials and Methods
Chemicals and reagents. OC and deuterium-
labeled OC (OC-D3) standards were provided 
by F. Hoffmann-La Roche Ltd. (Pharma 
Research, Basel, Switzerland). Acetonitrile 
(LC-MS grade), methanol (LC-MS grade), for-
mic acid, ascorbic acid, sodium chloride, and 
ammonia solution (25%) were purchased from 
Wako Pure Chemical Industry, Ltd. (Osaka, 
Japan). Individual standard stock solutions of 
OC and OC-D3 (1 mg/10 mL), prepared by 
weighing and dissolving the compounds in 
methanol, were stored at –20°C. All working 
standards were prepared from stock solution 
within 2 days before analysis and stored at 4°C 
for a maximum of 3 days.
Site description. All sampling points were 
located in the Katsura River catchment, cov-
ering river water and STP discharges. The 
Katsura River receives high anthropogenic 
inputs, including > 80% of waste  water gen-
erated from Kyoto City (1,389,000 people) 
and is the final outlet of STPs A, B, and C 
(Figure 2). STP B has two discharge points, 
one to the Katsura River (S2) and the other to 
the Nishitakase River (S3; Figure 2); around 
90% of the water in the Nishitakase River 
during dry weather comes from STPs A and B. 
River-water sampling point R1 was the most 
upstream point on the Katsura River, and R7 
was the most downstream point. 
Extraction method optimization. We 
adjusted the pH of Milli-Q water (Millipore, 
Billerica, MA) with 0.1 M sulfuric acid or 
10% ammonia solution to 4.0, 7.0, and 11.0 
to examine the effect of pH on the extrac-
tion efficiency of the SPE cartridge. To study 
breakthrough, we tested volumes of 100, 300, 
500, and 1,000 mL using OC-free samples 
spiked with OC and OC-D3 at 50 ng/L, and 
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Ba c k g r o u n d: Oseltamivir phosphate (OP; Tamiflu) is a prodrug of the anti-influenza neuraminidase 
inhibitor oseltamivir carboxylate (OC) and has been developed for the treatment and prevention of 
both A and B strains of influenza. The recent increase in OP resistance in influenza A virus (H1N1; 
commonlly called “swine flu”) has raised questions about the widespread use of Tamiflu in seasonal 
epidemics and the potential ecotoxicologic risk associated with its use in the event of a pandemic.
oBjectives: The objectives of this study were to develop an analytical method for quantitative deter-
mination of OC in sewage treatment plant (STP) effluent and receiving river water, and to investi-
gate the occurrence of OC in STP effluent and river water in Japan during a seasonal flu outbreak.
Me t h o d s : We developed an analytical method based on solid-phase extraction followed by liquid 
chromatography–tandem mass spectrometry. Using this method, we analyzed samples from three 
sampling campaigns conducted during the 2008–2009 flu season in Kyoto City, Japan. 
re s u l t s: The highest concentration of OC detected in STP discharge was 293.3 ng/L from a 
conventional activated-sludge–based STP; however, we detected only 37.9 ng/L from an advanced 
STP with ozonation as a tertiary treatment. In the receiving river water samples, we detected   
6.6–190.2 ng/L OC, during the peak of the flu season. 
co n c l u s i o n: OC is present in STP effluent and river water only during the flu season. Ozonation 
as tertiary treatment in STP will substantially reduce the OC load in STP effluent during an influ-
enza epidemic or pandemic.
key w o r d s : influenza, LC-MS/MS, oseltamivir carboxylate, river water, sewage discharge, Tamiflu. 
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we enriched sample matrixes on two stacked 
cartridges.
Sample collection and preparation. We 
assayed for OC in STP effluent and receiving 
river water during three 1-day-long sampling 
campaigns (dry weather conditions): the weeks 
beginning 4 December 2008, 4 February 2009, 
and 24 February 2009. Samples were collected 
from 11 locations: sampling points S1–S4 refer 
to STP discharge sites, and R1–R7 are to river 
sites (Figure 2). Sewage effluent samples were 
always gathered from the outlet of STPs, and 
river samples from a bridge over the center of 
the stream. No samples were collected at R2 
during the first and third campaigns or from 
S4 during the third campaign.
Grab samples (300 mL) were collected in 
glass bottles containing ascorbic acid (1 g/L) 
to acidify the samples and for chlorine and 
ozone quenching. All the samples were fil-
tered (Whatman GF/B glass microfiber filter, 
1 µm pore size) as soon as possible, but no 
more than 5 hr after sampling. The filtered 
samples were immediately extracted or kept 
at –25°C in half-filled amber glass bottles laid 
horizontally until extraction. Before extrac-
tion, sodium chloride (1 g/L) was added and 
the pH was adjusted to 4.0 with sulfuric acid 
to enhance OC extraction yield by SPE; the 
surrogate standard OC-D3 (50 ng) was added 
to calculate the recovery rate. SPE was per-
formed with 6-cc Oasis HLB sorbent car-
tridges (200 mg; Waters Co., Milford, MA, 
USA) using a Chratec Sep-Pak Concentrator 
(SPC 10-C; Chratec, Kyoto, Japan). The car-
tridges were preconditioned with 3 mL metha-
nol followed by 3 mL Milli-Q water (pH 4.0). 
All samples were passed through the cartridges 
at a flow rate of 5 mL/min. After concentra-
tion, the cartridges were dried completely with 
air on a vacuum manifold for 2 hr. The ana-
lytes were then eluted from the cartridge with 
6 mL methanol containing 2% ammonia, 
passed through a Sep-Pak Plus NH2 (360 mg; 
Waters) cartridge for cleanup into 10-mL 
graduated glass vessels, and dried by a gentle 
flow of nitrogen at 37°C. The final sample 
volume was adjusted to 0.5 mL with 0.1% 
formic acid in Milli-Q water containing 20% 
acetonitrile (a concentration factor of 600).
LC-MS/MS. OC and OC-D3 were sepa-
rated in a Waters Acquity Ultra Performance 
LC (UPLC) separation module with a binary 
pump system equipped with a UPLC BEH 
C18 column (100 mm × 2.1 mm, 1.7 µm par-
ticle size). Optimum separation was achieved 
with a binary gradient of 0.1% formic acid 
(vol/vol) in water (solvent A) and acetonitrile 
(solvent B) at a flow rate of 0.35 mL/min 
under the following program: 0–2 min, 10% 
B; 2–4 min, 10–75% B; 4–4.3 min, 75–90% 
B; 4.3–5.3 min, 90% B; 5.3–5.8 min, 
90–10% B; 5.8–8 min, 10% B (equilibration 
of column). The column temperature was 
kept at 60°C, and the injected sample volume 
was 10 µL. The UPLC system was coupled to 
a Quattro Micro API MS with electrospray 
ionization (Waters).
During quantification optimization, OC 
and OC-D3 were individually infused as stan-
dard solutions into the initial mobile phase 
(50% solvent A + 50% solvent B) directly into 
the MS at 1 mg/L at a cone voltage of 20 V, a 
collision energy of 10 eV, a product ion m/z of 
285.06 (OC) or 288.07 (OC-D3), a daughter 
ion m/z of 196.72 (OC) or 199.71 (OC-D3), 
and a retention time of 3.24 min. The MS 
used an electrospray source block temperature 
of 120°C and a desolvation temperature of 
400°C, a capillary voltage of 2.5 kV, and cone 
and desolvation gas flows of 50 and 900 L/hr, 
respectively. Instrument control, data acquisi-
tion, and quantification were performed by 
Mass Lynx 4.1 software (Waters).
Method validation. We anlyzed OC and 
OC-D3 by multiple reaction monitoring at 
the highest precursor and product ion transi-
tions. Positive identification of OC was based 
on LC retention time compared with that 
of OC-D3 surrogate standard, and < 0.05% 
deviation of retention time was tolerated. 
Seven-point calibration curves were con-
structed for quantification, ranging between 
0.5 and 400 ng/mL. The accuracy of the over-
all analytical procedure was evaluated with 
blank river water and STP discharge sam-
ples, that is, free of OC (collected on 12, 17, 
and 30 June 2008 during dry weather in the 
non-flu season), spiked at 100 ng/L and ana-
lyzed in quintuplicate, and compared with 
a direct injection of a standard mixture at 
the same concentration. Blank samples were 
previously analyzed to confirm the absence of 
any significant peak at the selected transition. 
Reproducibility was assessed by injection of 
OC-free sewage discharge and river water 
spiked at 50 ng/L (n = 5). The method was 
considered accurate if recoveries were in the 
range of 70–140%, and precision was satisfac-
tory if the relative SD was < 15%. The instru-
mental limit of detection (LOD) and limit of 
quantification (LOQ) were calculated from 
the SD of the repeated measurement (n = 5) 
of a standard solution (150 pg on column): 
LOD = 3 SD; LOQ = 10 SD. In a sample, 
OC was considered to be quantifiable when 
the signal of the peak was ≥ 10× the back-
ground noise.
Prediction of OC in STP discharge. The 
concentration of OC in STP discharge on a 
given day was calculated using the following 
equation:
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where PCSTP is the predicted concentration of 
OC in STP discharge in Kyoto City; TIC is 
the total number of influenza cases per week 
in Kyoto City during the study period; D is 
the OP dose assuming 85% adults (2 × 75 mg 
OP/day) and 15% children (2 × 45 mg OP/
day), reflecting the population structure of 
Kyoto City in 2008; 0.7 reflects that on any 
day in the week only five of seven patients will 
be taking OP because the treatment course is 
5 days; 0.8 represents the 80% of ingested 
OP that is excreted unaltered; P is the total 
population of Kyoto City (1,389,000); and 
300 is the average per capita water use (liters 
per person per day). Further, we assumed that 
all confirmed influenza cases were treated with 
OP and that there was zero degradation of 
OC in the conventional STPs (B and C) (Fick 
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Figure 1. Structure of the prodrug OP, its active metabolite OC, and OC-D3.
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Figure 2. Location of sampling points in the context 
of Japan (inset). S1 (STP A), S2 (STP B), S3 (STP B), 
and S4 (STP C) are sampling points for STP dis-
charges. R1–R7 indicate sampling points for river 
water. Oseltamivir carboxylate in the environment
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 1 | January 2010  105
et al. 2007). This assumption is not applicable 
to STP A, which uses ozonation-based tertiary 
treatment, which efficiently removes pharma-
ceuticals in wastewater and drinking water 
(Huber et al. 2003; Ternes et al. 2003).
Results and Discussion
Method validation and application. The pH 
of the sample proved to be the most influen-
tial variable during sample enrichment on the 
SPE cartridge. Extraction efficiency decreased 
as pH increased: it was 22% less at pH 11.0 
than at pH 4.0. We therefore selected pH 4.0. 
We used a sample volume of 300 mL, which 
was the maximum volume without a cartridge 
breakthrough.
The extraction yield of the surrogate stan-
dard OC-D3 was analogous to that of OC, 
as expected, owing to their similarities in 
physico  chemical properties. Thus, the ana-
lyte was quantitatively enriched by one car-
tridge and exhaustively eluted as described in 
“Materials and Methods.” The Sep-Pak Plus 
NH2 cartridge for cleanup during elution 
reduced matrix effects and markedly increased 
the peak sharpness and instrument sensitivity. 
The standard curves were linear, with correla-
tion factors typically > 0.99, between 5 and 
4,000 pg on the column. The precision of 
the entire method (reproducibility) ranged 
between 2% and 7.4%. The resulting recover-
ies were 128% ± 11% from STP effluent and 
110% ± 8% from river water. The extraction 
yield in the sample was determined from peak 
area ratios of analyte and surrogate standard. 
The method LOD and LOQ for OC were 
3.6 and 12 ng/L, respectively. Representative 
chromatograms of OC and OC-D3 at LOQ 
are shown in Figure 3. The method was suc-
cessfully applied to the analyses of river water 
and STP samples (Figure 4).
OC in STP discharge and river water. We 
measured OC concentration only in liquid 
phase (GF/B filtered sample). OC has both 
amine and carboxylate groups, a low partition 
coefficient (log P of 1.1), and a high water 
solubility (588 mg/mL at 25°C) (Singer et al. 
2007). These physico  chemical properties indi-
cate a very low potential for sorption to sus-
pended solids during treatment, so the load in 
the solid phase in sewage effluent will be low. 
We found OC in all STP discharges during all 
three sampling campaigns, at concentrations 
up to 293.3 ng/L (Figure 4B).
The first sampling campaign ran at the 
beginning of the flu season (Figure 4A). Only 
27 confirmed cases were reported that week; 
OC was detected in all STP discharges but 
not in the river water samples (Figure 4B). 
The highest concentration (18.2 ng/L) was 
detected at sampling point S2, a discharge 
point of STP B, an activated-sludge–based 
STP (Table 1). A slightly lower concentration 
(16.2 ng/L) was detected at point S3, another 
discharge point of STP B. During sampling, 
the average flow rates were 431,940 m3/day 
at S2 and 105,150 m3/day at S3, implying an 
OC load of 7.8 g/day to the Katsura River and 
1.7 g/day to the Nishitakase River. STP C, 
another activated-sludge–based STP (Table 1), 
also discharges to the Katsura River. At S4, 
the OC concentration was 12.0 ng/L, with an 
OC load of 1.6 g/day. The predicted OC con-
centration (Equation 1) in STP discharge was 
4.0 ng/L, much lower than the maximum con-
centration detected at STP B (Figure 5). Our 
prediction was based on confirmed flu cases 
reported by the Kyoto City office, so there 
could be a gap between the doses of Tamiflu 
taken and the number of confirmed cases. 
The results also suggest the preventive use of 
Tamiflu (75 mg/day for 10 days) to help con-
trol flu outbreaks among people at high risk, 
such as in nursing homes or hospital wards. 
This would explain our under  estimate. The 
OC concentration was 6.3 ng/L at point S1 
(STP A), with an OC load of 0.35 g/day to the 
Nishitakase River, substantially lower than at 
STPs B and C (this was true of all campaigns). 
STP A uses ozonation (4 mg ozone/L for an 
average contact time of 10 min) as a tertiary 
treatment (Table 1). This is the key factor in 
the lower level of OC at STP A. This finding 
reveals that the assumption of zero removal of 
OC may not be appropriate for the prediction 
of concentration in effluent without an evalua-
tion of the effect of ozonation on OC.
The second sampling campaign ran dur-
ing the peak period of the 2008–2009 flu 
season in Kyoto City. The city recorded 
1,738 cases during week. OC was detected 
at all sampling points, with the highest con-
centration at point S3 (293.3 ng/L). The pre-
dicted concentration of OC in STP discharge 
was 311 ng/L, very close to the actual maxi-
mum. The number of patients increased by 
a factor of 60 between the first and second 
campaigns, but the concentration of OC in 
STP discharge increased by a factor of only 
20. This difference could be due to a decrease 
in the prophylactic use of Tamiflu since the 
beginning of the flu outbreak and to the use 
of Zanamivir (another neuraminidase inhibi-
tor; GlaxoSmithKline, Tokyo, Japan) instead 
of Tamiflu in some cases, because Tamiflu-
resistant H1N1 virus was recorded during 
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the 2008–2009 flu season in Japan (WHO 
2009). At sampling point R1, in the Katsura 
River upstream of STP B (S2), the river incor-
porates waste  water from a small city and hilly 
areas, and had a relatively low concentration 
of OC (6.6 ng/L) (Figure 4C). Similarly, the 
concentration was low at Kamo River sam-
pling point R3 (8.2 ng/L), which also has 
low levels of anthropogenic contaminants. 
On the other hand, the Nishitakase River 
carries treated sewage from STP A (S1) and 
STP B (S3), accounting for around 90% of 
its total flow, and had a high concentration 
of OC at R2 (190.2 ng/L), as expected. The 
Nishitakase and Kamo rivers join the Katsura 
River upstream of R5, where the OC concen-
tration was 13.1 ng/L, comparable to that at 
the most downstream point, R7 (11.6 ng/L). 
The OC concentrations at R4 and R6 were 
11.3 and 19.6 ng/L, respectively.
During the third sampling campaign, 
OC was again detected only in STP efflu-
ent: 9.0 ng/L at S1, 74.6 ng/L at S2, and 
72.7 ng/L at S3.
Transport, dissipation, and degradation. 
During the non-flu period (June–October 
2008), OC was not detected in sewage dis-
charge (S1, S2, S3) or river water (R5). The 
Katsura River is the main river in the study 
area, receiving most of the wastewater gener-
ated from Kyoto City. The OC concentration 
increased from point R1 (6.6 ng/L) down-
stream to R5 (13.1 ng/L) during the flu season 
(Figure 4C). Discharges from STPs A and B 
were the main sources involved in this increase. 
There was no effect of dilution between R1 and 
R5 because a higher concentration of OC was 
detected at the Kamo River sampling site (R3; 
8.2 ng/L) than at R1. The OC concentration 
at the most downstream point on the Katsura 
River (R7; 17.1 ng/L) was higher than that at 
R5. The addition of OC from STP C effluent 
(S4; 172.0 ng/L) and a small canal between R5 
and R7 (R6; 19.6 ng/L) was responsible for 
the higher concentration at R7 than at R5. As 
is the case for other pharmaceuticals, OC may 
degrade by sorption, biodegradation, and pho-
tolysis. In river water, OC can be degraded by 
the addition of a small amount (5%) of sedi-
ment, which promotes microbial degradation 
but requires several weeks (> 8% of 14C-OC 
evolved as 14CO2 from water/sediment sam-
ples after 21 days of incubation) (Saccà et al. 
2009). Because OC has a low sorption affin-
ity for sediment, sorption would explain little 
degradation (Saccà et al. 2009). Because the 
river flow in the study area is fast (complete 
transit in a few hours), the removal of OC by 
sorption and biodegradation between R1 and 
R7 will be insignificant. On the other hand, 
direct photolysis plays little or no role in the 
decomposition of OC: The half-life of OC in 
unfiltered Elbe River water was 427 hr (Bartels 
and Tümpling 2008). Thus, OC will persist in 
water, and a substantial load reduction of OC 
from STPs may be required in the event of an 
influenza epidemic or pandemic.
STPs A, B, and C are located in Kyoto City 
and treat mainly domestic wastewater. STP A 
also receives industrial effluent from small-scale 
factories that manufacture kimonos (traditional 
Japanese dress), accounting for < 10% of its 
total volume. The samples were collected dur-
ing dry weather, and surface runoff was neg-
ligible. Under these circumstances, the OC 
concentration in the STP A discharge should 
be similar to those at STPs B and C. Yet during 
the second sampling campaign, the maximum 
OC concentrations were 37.9 ng/L at STP A, 
293.3 ng/L at STP B, and 172 ng/L at STP C. 
Ozonation at STP A explains the low concen-
tration there (Huber et al. 2003; Ternes et al. 
2003). We conclude that ozonation will sub-
stantially reduce the OC load in STP effluent 
during an influenza epidemic or pandemic.
Environmental risk. The highest OC con-
centrations were detected during the second 
sampling campaign: 293.3 ng/L at STP A site 
S3 and 190.2 ng/L at Nishitakase River site 
R2. The Nishitakase carries mostly STP A and 
STP B effluent on dry days, resulting in its high 
concentration. The predicted environmental 
levels of OC during a flu pandemic in Europe 
and North America ranged from < 300 ng/L to 
32 µg/L, depending on the characteristics of the 
river basins (Singer et al. 2007). In the Katsura 
River, the highest concentration was 17.1 ng/L 
at R7, the most downstream point in the pres-
ent study. In an acute toxicity study using 
Daphnia magna, Tamiflu was classified harm-
ful according to European Union Directive 
67/548/EEC as amended (European Medicines 
Agency 2005). However, on the basis of “pre-
dicted environmental concentration/predicted 
no-effect concentration” risk ratios, no signifi-
cant risk of surface waters or STP effluent dur-
ing both seasonal and pandemic use of Tamiflu 
was evident (Straub 2009). Nitrification in 
STPs is generally considered to be sensitive 
to toxic compounds (Pagga et al. 2006). Yet 
concentrations of OC up to 20 µg/mL had 
no observed impact on the structure of the 
microbial community or on bacterial nitrifi-
cation processes (Saccà et al. 2009). The risk 
of OC resistance in wildfowl was considered 
less important than the synergistic effects of 
pharmaceuticals in sewage on the biological 
sewage treatment process (Singer et al. 2008). 
However, the concentration that inhibited 50% 
of influenza virus (IC50) ranged between 80 
and 230 ng/L (Gubareva et al. 2001; Monto 
et al. 2006), similar to the range detected in 
STP discharge here. The emergence of resis-
tance to Tamiflu in the influenza virus H1N1 
during the 2008–2009 flu season are of great 
concern (WHO 2009). During a common flu 
season, waterfowl can ingest large quantities of 
OC with virus (virus is believed to be transmit-
ted among waterfowl by the fecal–oral route) in 
their daily water intake, and a high percentage 
of OC ingested by waterfowl will remain in the 
intestinal tract, the primary site of viral replica-
tion, possibly promoting drug resistance (Fick 
et al. 2007; Singer et al. 2007).
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Figure 5. Total number of influenza cases reported per week with predicted and maximum detected 
  concentrations of OC in Kyoto City sewage discharges (see Equation 1 for assumptions).
Table 1. STP characteristics.
Treatment processes
STP Capacity (m3/day) Population served Primary Secondary Tertiary
A 114,000 83,000 Settling AOAO O3
B 975,000 773,000 Settling CAS, A2O, AOAO
C 228,000 338,167 Settling AOAO
Abbreviations: A2O, anaerobic/anoxic/oxic; AOAO, anoxic/oxic/anoxic/oxic; CAS, conventional activated sludge; O3, 
ozonation (4 mg ozone/L; average contact time, 10 min).Oseltamivir carboxylate in the environment
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Conclusion
We developed and validated an LC-MS/MS– 
based analytical method for the determina-
tion of OC in water samples. Here, we report 
for the first time the detection of OC in STP 
discharges and river water during a flu season. 
The highest concentration of OC detected 
in STP discharge was 293.3 ng/L at an STP 
operating with only an activated-sludge–based 
treatment system. One STP operating with 
ozonation as a tertiary treatment was highly 
efficient at removing OC (> 85% from sec-
ondary effluent). Ozonation as tertiary treat-
ment in STP will substantially reduce the OC 
load in STP effluent during an influenza epi-
demic or pandemic. Further research should 
investigate the fate of antiviral drugs during 
every process at every unit in the STPs.
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